Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
ARTIS Ventures is a prominent venture capital firm founded in San Francisco, California, dedicated to supporting visionary founders who are advancing global resilience through critical technologies. Established with a mission to invest in essential systems that impact people worldwide, ARTIS Ventures focuses on catalyzing breakthroughs in various sectors, particularly in healthcare, biotechnology, and frontier technologies. The firm operates with a clear investment thesis that emphasizes the importance of scalable and accessible health systems, infrastructure, and security frameworks that protect vital systems for human life.
With a portfolio comprising seven innovative companies, ARTIS Ventures has positioned itself as a key player in the venture capital landscape. The firm is known for its strategic investments that not only aim for financial returns but also contribute to societal well-being. By leveraging its expertise and resources, ARTIS Ventures seeks to empower startups that are at the forefront of technological advancements, particularly those that intersect with biology and health.
ARTIS Ventures has a well-defined investment focus that targets startups dedicated to strengthening global resilience and protecting vital systems for human life. The firm invests across various stages, including seed, Series A, Series B, and growth equity, allowing it to support companies at different points in their development. The sectors of interest for ARTIS Ventures include healthcare, biotechnology, and frontier technologies, with a particular emphasis on the convergence of technology and biology.
The firm looks for innovative solutions that enhance health systems, improve infrastructure, and develop security frameworks that are both scalable and accessible. By prioritizing investments in these areas, ARTIS Ventures aims to back companies that are not only technologically advanced but also have the potential to make a significant impact on global health and safety. Founders who align with this vision and are working on transformative technologies in these sectors are particularly well-suited for partnership with ARTIS Ventures.
ARTIS Ventures boasts a diverse portfolio of seven notable companies that exemplify its commitment to advancing healthcare and biotechnology innovation. Among these, **Eko** stands out for its development of non-invasive devices and algorithms aimed at improving cardiovascular care. **Conceivable** is another key investment, focusing on next-generation fertility science through the integration of genomics and artificial intelligence.
Additionally, **Rad AI** enhances efficiency and patient outcomes in radiology by utilizing artificial intelligence, while **Freenome** offers next-generation blood tests designed for early cancer detection. Other significant portfolio companies include **Aether Biomachines**, which works on repurposing enzymes to create new compounds, and **Modern Meadow**, known for its development of sustainable biomaterials. Lastly, **Viacyte** aims to provide a functional cure for Type 1 Diabetes, showcasing the firm’s commitment to impactful health solutions. This diverse portfolio reflects ARTIS Ventures' strategic focus on companies that are pioneering advancements in critical technologies.
ARTIS Ventures invests across multiple stages, including seed, Series A, Series B, and growth equity. This allows them to support startups at various points in their development journey, from early-stage innovations to more established companies seeking growth capital.
The firm primarily focuses on healthcare, biotechnology, and frontier technologies. ARTIS Ventures is particularly interested in the convergence of technology and biology, seeking to invest in startups that enhance global resilience and protect vital systems for human life.
While specific check sizes are not detailed in the provided information, ARTIS Ventures invests across various stages, which typically suggests a range of investment amounts depending on the stage of the company and its specific needs.
ARTIS Ventures primarily invests in North America. Their focus on this region allows them to engage with a robust ecosystem of innovative startups and technologies.
The application process details are not specified in the provided information. However, founders interested in pitching to ARTIS Ventures should prepare to present their innovative solutions and how they align with the firm’s investment thesis.
While specific support mechanisms are not outlined, ARTIS Ventures is known for empowering visionary founders and advancing critical technologies, suggesting that they likely offer strategic guidance and resources to their portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.